Merit Financial Group, LLC Sorrento Therapeutics, Inc. Transaction History

Merit Financial Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$1.24 - $2.33 $4,836 - $9,087	-3,900 Reduced 22.06%	13,780 $28,000
Q4 2021 Feb 14, 2022	SELL	$4.65 - $7.23 $18,600 - $28,920	-4,000 Reduced 18.45%	17,680 $82,000
Q2 2021 Aug 16, 2021	BUY	$6.35 - $10.0 $6,350 - $10,000	1,000 Added 4.84%	21,680 $210,000
Q1 2021 May 18, 2021	BUY	$7.03 - $16.51 $7,030 - $16,510	1,000 Added 5.08%	20,680 $171,000
Q3 2020 Nov 10, 2020	BUY	$6.17 - $18.82 $35,045 - $106,897	5,680 Added 40.57%	19,680 $219,000
Q2 2020 Aug 13, 2020	BUY	$1.73 - $6.76 $24,220 - $94,640	14,000 New	14,000 $88,000

5.53M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Merit Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Merit Financial Group, LLC with notifications on news.